Reprint

Clinical Advances in Cerebral Aneurysm Treatment

Edited by
May 2024
136 pages
  • ISBN978-3-7258-1213-4 (Hardback)
  • ISBN978-3-7258-1214-1 (PDF)

This book is a reprint of the Special Issue Clinical Advances in Cerebral Aneurysm Treatment that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

The objective of this reprint is to offer readers the most up-to-date insights into managing both ruptured and unruptured cerebral aneurysms. Despite recent advancements in diagnosing and treating these aneurysms, their associated complications significantly affect patient outcomes at various stages of the disease. The early identification and effective management of potential complications are therefore crucial. Additionally, selecting appropriate candidates for preventive treatment and refining treatment strategies can further enhance outcomes. Within this reprint, neurovascular specialists from around the globe contribute their research findings and perspectives on various aspects of cerebral aneurysm management. These contributions aim to deepen our understanding of the pathophysiological mechanisms behind this complex condition and pave the way for optimizing treatment guidelines in the future.

Format
  • Hardback
License and Copyright
© 2024 by the authors; CC BY-NC-ND license
Keywords
intracranial aneurysm; treatment; subarachnoid hemorrhage; vasospasm; delayed ischemic neurological deficit; intracranial aneurysm; treatment; subarachnoid hemorrhage; vasospasm; delayed ischemic neurological deficit; balloon angioplasty; intra-arterial spasmolysis; subarachnoid hemorrhage; anemia; outcome; risk factors; aneurysmal subarachnoid hemorrhage; vasospasm; delayed cerebral ischemia; early brain injury; spreading depolarization; subarachnoid hemorrhage; intracranial aneurysm; direct oral anticoagulants; vitamin K antagonists; subarachnoid hemorrhage; ventricular measurements; inflammation; marker; decompressive craniectomy; flow diversion; low-profile flow diverter; small cerebral vessels; Silk Vista Baby; p48MW; coating; intracranial aneurysm; treatment; subarachnoid hemorrhage; vasospasm; delayed ischemic neurological deficit; unruptured intracranial aneurysms; microsurgery; endovascular; observation; management; anterior communicating artery; morbidity; mortality; unruptured intracranial aneurysm; anterior communicating artery; UIATS; PHASES; concordance; n/a